54029-12-8 | methyl N-[5-(propane-1-sulfinyl)-1H-1,3-benzodiazol-2-yl]carbamate

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$14.00	$10.00
5g	98%	in stock	$24.00	$17.00
25g	98%	in stock	$63.00	$44.00

Description

• Catalog Number: AI52108
• Chemical Name: methyl N-[5-(propane-1-sulfinyl)-1H-1,3-benzodiazol-2-yl]carbamate
• CAS Number: 54029-12-8
• Molecular Formula: C12H15N3O3S
• Molecular Weight: 281.3308
• MDL Number: MFCD00797922
• SMILES: CCCS(=O)c1ccc2c(c1)[nH]c(n2)NC(=O)OC

Computed Properties

• Complexity: 353
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 19
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 5
• Undefined Atom Stereocenter Count: 1
• XLogP3: 1.4

Literature

• A novel MDCKII in vitro model for assessing ABCG2-drug interactions and regulation of ABCG2 transport activity in the caprine mammary gland by environmental pollutants and pesticides.

  Toxicology in vitro : an international journal published in association with BIBRA 20140401

• Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor.

  Scientific reports 20140101

• Relative potency of albendazole and its sulfoxide metabolite in two in vitro tests for developmental toxicity: the rat whole embryo culture and the mouse embryonic stem cell test.

  Reproductive toxicology (Elmsford, N.Y.) 20121101

• Dose-dependent systemic exposure of albendazole metabolites in lambs.

  Journal of veterinary pharmacology and therapeutics 20120801

• Enantiomeric resolution of albendazole sulfoxide by semipreparative HPLC and in vitro study of growth inhibitory effects on human cancer cell lines.

  Journal of pharmaceutical and biomedical analysis 20120701

• Albendazole sulfoxide enantiomers: preparative chiral separation and absolute stereochemistry.

  Journal of chromatography. A 20120323

• Assessment of the stereoselective fungal biotransformation of albendazole and its analysis by HPLC in polar organic mode.

  Journal of pharmaceutical and biomedical analysis 20120305

• Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration.

  Environmental toxicology and pharmacology 20120301

• Voluntary ingestion of antiparasitic drugs emulsified in honey represents an alternative to gavage in mice.

  Journal of the American Association for Laboratory Animal Science : JAALAS 20120301

• Highly sensitive LC-MS/MS-ESI method for simultaneous quantitation of albendazole and ricobendazole in rat plasma and its application to a rat pharmacokinetic study.

  Biomedical chromatography : BMC 20120201

• A simple LC-MS/MS method to determine plasma and cerebrospinal fluid levels of albendazole metabolites (albendazole sulfoxide and albendazole sulfone) in patients with neurocysticercosis.

  Biomedical chromatography : BMC 20120201

• Ultrastructural changes in the advanced third larval stage of Gnathostoma binucleatum Almeyda-Artigas, 1991 (Nematoda: Spirurida) following albendazole and albendazole sulfoxide in vitro exposure.

  Parasitology research 20120201

• Short Communication: In Vitro Efficacy Testing of Praziquantel, Ivermectin, and Oxfendazole against Taenia Solium Cysts.

  Journal of parasitology research 20120101

• Inoperable cerebral alveolar echinococcosis controlled with high dosages of albendazole adjusted with monitoring of blood levels.

  Journal of travel medicine 20120101

• Different stability-indicating chromatographic techniques for the determination of netobimin.

  Journal of analytical methods in chemistry 20120101

• Potential of thermophilic fungus Rhizomucor pusillus NRRL 28626 in biotransformation of antihelmintic drug albendazole.

  Applied biochemistry and biotechnology 20111101

• Application of ultra-performance columns in high-performance liquid chromatography for determination of albendazole and its metabolites in turkeys.

  Biomedical chromatography : BMC 20111001

• Capillary electrophoresis and hollow fiber liquid-phase microextraction for the enantioselective determination of albendazole sulfoxide after biotransformation of albendazole by an endophytic fungus.

  Electrophoresis 20111001

• In vitro effects of some herbs used in Egyptian traditional medicine on viability of protoscolices of hydatid cysts.

  The Korean journal of parasitology 20110901

• Simultaneous determination of albendazole and its metabolites in fish muscle tissue by stable isotope dilution ultra-performance liquid chromatography tandem mass spectrometry.

  Analytical and bioanalytical chemistry 20110801

• Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.

  British journal of clinical pharmacology 20110701

• Albendazole sulphoxide kinetic disposition after treatment with different formulations in dogs.

  Journal of veterinary pharmacology and therapeutics 20110401

• Evaluation of potential embryo toxicity of albendazole sulphoxide in CF1 mice.

  Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al 20110401

• Stimulation of pro-inflammatory responses by mebendazole in human monocytic THP-1 cells through an ERK signaling pathway.

  Archives of toxicology 20110301

• The transport of albendazole and albendazole sulphoxide in the lancet fluke (Dicrocoelium dendriticum).

  Veterinary parasitology 20110227

• In vitro evaluation of the effects of cysticidal drugs in the Taenia crassiceps cysticerci ORF strain using the fluorescent CellTracker CMFDA.

  Experimental parasitology 20110101

• First report of anthelmintic resistance in gastrointestinal nematodes of sheep from costa rica.

  Veterinary medicine international 20110101

• Simultaneous determination of benzimidazoles and their metabolites in plasma using high-performance liquid chromatography/tandem mass spectrometry: application to pharmacokinetic studies in rabbits.

  Journal of AOAC International 20110101

• Role of albendazole in the management of hydatid cyst liver.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20110101

• Characterization of the xenobiotic response of Caenorhabditis elegans to the anthelmintic drug albendazole and the identification of novel drug glucoside metabolites.

  The Biochemical journal 20101215

• Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-beta-cyclodextrin following subcutaneous injection in sheep.

  International journal of pharmaceutics 20100915

• In vitro oxidative metabolism of xenobiotics in the lancet fluke (Dicrocoelium dendriticum) and the effects of albendazole and albendazole sulphoxide ex vivo.

  Xenobiotica; the fate of foreign compounds in biological systems 20100901

• Development and oral bioavailability assessment of a supersaturated self-microemulsifying drug delivery system (SMEDDS) of albendazole.

  The Journal of pharmacy and pharmacology 20100901

• Tissue compatibility and pharmacokinetics of three potential subcutaneous injectables for low-pH drug solutions.

  The Journal of pharmacy and pharmacology 20100701

• Microbial transformation of albendazole.

  Indian journal of experimental biology 20100401

• Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.

  PLoS neglected tropical diseases 20100201

• The influence of ovarian cancer induced peritoneal carcinomatosis on the pharmacokinetics of albendazole in nude mice.

  Anticancer research 20100201

• Residue depletion of albendazole and its metabolites in the muscle tissue of large mouth and hybrid striped bass after oral administration.

  Journal of chromatography. A 20091113

• Population pharmacokinetics of albendazole in patients with neurocysticercosis.

  International journal of clinical pharmacology and therapeutics 20091101

• Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazole.

  British journal of clinical pharmacology 20091101

• Comparative in vitro effect of artemether and albendazole on adult Toxocara canis.

  Parasitology research 20091001

• Effect of ritonavir on the pharmacokinetics of the benzimidazoles albendazole and mebendazole: an interaction study in healthy volunteers.

  European journal of clinical pharmacology 20091001

• Intra-cystic drug concentration of albendazole sulphoxide in patients with Echinococcus granulosus cysts.

  The American journal of tropical medicine and hygiene 20091001

• Enantiomeric behaviour of albendazole and fenbendazole sulfoxides in domestic animals: pharmacological implications.

  Veterinary journal (London, England : 1997) 20090901

• Liquid chromatography/mass spectrometric identification of benzimidazole anthelminthics metabolites formed ex vivo by Dicrocoelium dendriticum.

  Rapid communications in mass spectrometry : RCM 20090901

• Stability of ricobendazole in aqueous solutions.

  Journal of pharmaceutical and biomedical analysis 20090712

• Effect of age and gender in the pharmacokinetics of albendazole and albendazole sulphoxide enantiomers in goats.

  Research in veterinary science 20090601

• Pharmacological assessment of netobimin as a potential anthelmintic for use in horses: plasma disposition, faecal excretion and efficacy.

  Research in veterinary science 20090601

• Synthesis and in vitro cysticidal activity of new benzimidazole derivatives.

  European journal of medicinal chemistry 20090401

• Phase I biotransformation of albendazole in lancet fluke (Dicrocoelium dendriticum).

  Research in veterinary science 20090201

• Albendazole enantiomeric metabolism and binding to cytosolic proteins in the liver fluke Fasciola hepatica.

  Veterinary research communications 20090201

• Use of albendazole sulfoxide, albendazole sulfone, and combined solutions as scolicidal agents on hydatid cysts (in vitro study).

  World journal of gastroenterology 20090107

• Diagnostic problems with parasitic and non-parasitic splenic cysts.

  BMC surgery 20090101

• The control of hookworm infection in China.

  Parasites & vectors 20090101

• [In vitro observation on albendazole sulfoxide and its enantiomers against Echinococcus granulosus protoscolex].

  Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases 20081230

• Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions.

  Pharmaceutical research 20081001

• Diagnosis and treatment of pulmonary cystic hydatidosis.

  Indian journal of pediatrics 20081001

• Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats.

  Veterinary journal (London, England : 1997) 20080801

• Determination of albendazole metabolites by direct injection of bovine plasma and multidimensional achiral-chiral high performance liquid chromatography.

  Talanta 20080630

• LC-MS-MS identification of albendazole and flubendazole metabolites formed ex vivo by Haemonchus contortus.

  Analytical and bioanalytical chemistry 20080501

• Kinetic disposition of albendazole in goats subclinically infected with gastrointestinal nematodes vis-à-vis naive animals following oral and intraruminal administration.

  Journal of helminthology 20080301

• Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials.

  PLoS neglected tropical diseases 20080301

• Determination of albendazole and its metabolites in the muscle tissue of hybrid striped and largemouth bass using liquid chromatography with fluorescence detection.

  Journal of AOAC International 20080101

• Simultaneous determination of albendazole metabolites, praziquantel and its metabolite in plasma by high-performance liquid chromatography-electrospray mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20070628

• Absorption and metabolism of albendazole after intestinal ischemia/reperfusion.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20070501

• Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts.

  The Journal of antimicrobial chemotherapy 20070201

• Pharmacokinetics of albendazole in New Zealand white rabbits: oral versus intraperitoneal administration.

  Anticancer research 20070101

• A dual anthelmintic treatment strategic scheme for the control of fasciolosis in dairy sheep farms.

  Parasitology research 20061101

• Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes.

  Veterinary research communications 20061001

• Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep.

  Journal of veterinary pharmacology and therapeutics 20060801

• Enantiomeric separation of chiral sulfoxides by supercritical fluid chromatography.

  Journal of separation science 20060701

• Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations.

  Transactions of the Royal Society of Tropical Medicine and Hygiene 20060401

• Role of ABC transporters in veterinary drug research and parasite resistance.

  Current drug delivery 20060401

• Evaluation of the efficacy of albendazole sulphoxide and praziquantel in combination on Taenia crassiceps cysts: in vitro studies.

  The Journal of antimicrobial chemotherapy 20060301

• Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.

  Neurology 20060214

• Variation among faecal egg counts following natural nematode infection in Scottish Blackface lambs.

  Parasitology 20060201

• An in vitro kinetic method for detection of precipitation of poorly soluble drugs.

  International journal of pharmaceutics 20051104

• Pharmacokinetics of ricobendazole after its intravenous, intraruminal and subcutaneous administration in sheep.

  Veterinary research communications 20051001

• Development and optimization of a rapid HPLC method for analysis of ricobendazole and albendazole sulfone in sheep plasma.

  Journal of pharmaceutical and biomedical analysis 20050901

• Liver microsomal biotransformation of albendazole in deer, cattle, sheep and pig and some related wild breeds.

  Journal of veterinary pharmacology and therapeutics 20050801

• Preoperative albendazole and scolices viability in patients with hepatic echinococcosis.

  World journal of surgery 20050601

• Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.

  Cancer chemotherapy and pharmacology 20050501

• Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2).

  Drug metabolism and disposition: the biological fate of chemicals 20050501

• Physicochemical characterization of ricobendazole: I. Solubility, lipophilicity, and ionization characteristics.

  Journal of pharmaceutical sciences 20050501

• Death related to albendazole-induced pancytopenia: case report and review.

  The American journal of tropical medicine and hygiene 20050301

• Highly sensitive ion pair liquid chromatographic determination of albendazole marker residue in animal tissues.

  Journal of agricultural and food chemistry 20050223

• Analytical and semipreparative resolution of enatiomers of albendazole sulfoxide by HPLC on amylose tris (3,5-dimethylphenylcarbamate) chiral stationary phases.

  Journal of biochemical and biophysical methods 20050131

• Inhibitory effect of albendazole and its metabolites on cytochromes P450 activities in rat and mouflon in vitro.

  Pharmacological reports : PR 20050101

• A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement.

  Journal of molecular graphics & modelling 20041201

• Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis.

  Chirality 20041001

• Quantitative determination of albendazole metabolites in sheep spermatozoa and seminal plasma by liquid chromatographic analysis with fluorescence detection.

  Journal of pharmaceutical and biomedical analysis 20040903

• Resistance to benzimidazole and macrocyclic lactone anthelmintics in cattle nematodes in Argentina.

  Veterinary parasitology 20040806

• Simultaneous determination of albendazole and its major active metabolite in human plasma using a sensitive and specific liquid chromatographic-tandem mass spectrometric method.

  Journal of pharmaceutical and biomedical analysis 20040629

• Reversed-phase liquid chromatographic method with fluorescence detection for the simultaneous determination of albendazole sulphoxide, albendazole sulphone and albendazole 2-aminosulphone in sheep plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040615

• Monitoring of drugs and metabolites in body fluids by capillary electrophoresis with XeHg lamp-based and laser-induced fluorescence detection.

  Electrophoresis 20040601

• Pharmacokinetic investigation of albendazole and praziquantel in Thai children infected with Giardia intestinalis.

  Annals of tropical medicine and parasitology 20040601

• Effect of the ionophore antibiotic monensin on the ruminal biotransformation of benzimidazole anthelmintics.

  Veterinary journal (London, England : 1997) 20040501

• Comparative hepatic and extrahepatic enantioselective sulfoxidation of albendazole and fenbendazole in sheep and cattle.

  Drug metabolism and disposition: the biological fate of chemicals 20040501

• [Influence of mobile phase composition on chiral separation of albendazole sulfoxide racemates].

  Se pu = Chinese journal of chromatography 20040501

• Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity.

  International journal for parasitology 20040401

• Ex vivo anthelmintic activity of albendazole-sulphoxide enantiomers.

  The Journal of parasitology 20040401

• The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs.

  International journal of pharmaceutics 20040319

• Albendazole sulphoxide concentrations in plasma of endemic normals from a lymphatic filariasis endemic region using liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040125

• Therapy for neurocysticercosis.

  Expert review of neurotherapeutics 20040101

• Quantitative chromatographic determination of several benzimidazole anthelmintic molecules in parasite material.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031205

• The effects of albendazole and its metabolites on hepatic cytochromes P450 activities in mouflon and rat.

  Research in veterinary science 20031201

• Effect of two formulations of benzimidazole carbamates on the viability of cysts of Echinococcus granulosus in vivo.

  Parasite (Paris, France) 20031201

• Metabolism and residue depletion of albendazole and its metabolites in rainbow trout, tilapia and Atlantic salmon after oral administration.

  Journal of veterinary pharmacology and therapeutics 20031201

• Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.

  Veterinary research communications 20031001

• Intestinal elimination of albendazole sulfoxide: pharmacokinetic effects of inhibitors.

  International journal of pharmaceutics 20030916

• Use of semipreparative supercritical fluid chromatography to obtain small quantities of the albendazole sulfoxide enantiomers.

  Journal of chromatography. A 20030905

• Ginseng increases intestinal elimination of albendazole sulfoxide in the rat.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20030901

• Stereospecific biotransformation of albendazole in mouflon and rat-isolated hepatocytes.

  Journal of veterinary pharmacology and therapeutics 20030801

• Time dependent pharmacokinetics of albendazole in human.

  Biopharmaceutics & drug disposition 20030701

• Analysis of albendazole metabolites by electrospray LC-MS/MS as a probe to elucidate electro-oxidation mechanism of albendazole.

  Journal of pharmaceutical and biomedical analysis 20030601

• Placental and fetal toxicity of albendazole sulphoxide in Wistar rats.

  Veterinary and human toxicology 20030601

• Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole.

  The Journal of pharmacy and pharmacology 20030601

• Determination of albendazole and its major metabolites in the muscle tissues of Atlantic salmon, tilapia, and rainbow trout by high performance liquid chromatography with fluorometric detection.

  Journal of agricultural and food chemistry 20030521

• Albendazole sulphoxide enantiomers in pregnant rats' embryo concentrations and developmental toxicity.

  Veterinary journal (London, England : 1997) 20030501

• The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.

  Annals of tropical medicine and parasitology 20030301

• Simultaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030105

• Transtegumental diffusion of benzimidazole anthelmintics into Moniezia benedeni: correlation with their octanol-water partition coefficients.

  Experimental parasitology 20030101

• Separation of albendazole sulfoxide enantiomers by chiral supercritical-fluid chromatography.

  Journal of biochemical and biophysical methods 20021231

• HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies.

  Journal of pharmaceutical and biomedical analysis 20021015

• Effect of gender in the disposition of albendazole metabolites in humans.

  European journal of clinical pharmacology 20020901

• Albendazole-soybean oil emulsion for the treatment of human cystic echinococcosis: evaluation of bioavailability and bioequivalence.

  Acta tropica 20020801

• Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.

  British journal of clinical pharmacology 20020801

• Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.

  Therapeutic drug monitoring 20020601

• Placental transfer of albendazole sulphoxide enantiomers in sheep.

  Veterinary journal (London, England : 1997) 20020301

• Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability.

  The American journal of tropical medicine and hygiene 20020301

• Albendazole metabolism in patients with neurocysticercosis: antipyrine as a multifunctional marker drug of cytochrome P450.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20020201

• In vitro ruminal biotransformation of benzimidazole sulphoxide anthelmintics: enantioselective sulphoreduction in sheep and cattle.

  Journal of veterinary pharmacology and therapeutics 20020201

• Capillary electrophoresis with (R)-(--)-N-(3,5-dinitrobenzoyl)-alpha-phenylglycine as chiral selector for separation of albendazole sulfoxide enantiomers and their analysis in human plasma.

  Journal of pharmaceutical and biomedical analysis 20020115

• Enantioselective binding of albendazole sulphoxide to cytosolic proteins from helminth parasites.

  Methods and findings in experimental and clinical pharmacology 20020101

• Laparoscopic treatment of hepatic hydatid cysts with a liposuction device.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20020101

• Ex vivo diffusion of albendazole and its sulfoxide metabolite into ascaris suum and Fasciola hepatica.

  Parasitology research 20011101

• Enantioselective analysis of albendazole sulfoxide in cerebrospinal fluid by capillary electrophoresis.

  Electrophoresis 20010901

• Pharmacokinetics of ricobendazole in calves.

  Journal of veterinary pharmacology and therapeutics 20010601

• Effect of ruminal microflora on the biotransformation of netobimin, albendazole, albendazole sulfoxide, and albendazole sulfoxide enantiomers in an artificial rumen.

  Journal of animal science 20010501

• Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites.

  Parasitology research 20010401

• Albendazole sulphoxide enantiomeric ratios in plasma and target tissues after intravenous administration of ricobendazole to cattle.

  Journal of veterinary pharmacology and therapeutics 20010401

• Pharmacokinetics of netobimin and microsomal metabolism of albendazole in infected gerbils with Echinococcus granulosus.

  Parasitology research 20010201

• [Efficacy of albendazole immunoliposome against echinococcosis granulosus in mice].

  Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases 20010101

• Effect of albendazole sulfoxide solution on the scolices and the hepatobiliary system.

  European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 19980101

• In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives.

  Antimicrobial agents and chemotherapy 19971201

• Discrepancy between in vitro and in vivo antifungal activity of albendazole.

  Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 19970101